3/23/2023  2:36:14 PM Chg. +1.03 Volume Bid2:37:37 PM Ask2:36:14 PM Market Capitalization Dividend Y. P/E Ratio
129.20CHF +0.80% 8,888
Turnover: 1.14 mill.
128.85Bid Size: 28 129.30Ask Size: 30 20.59 bill.CHF 0.52% 51.93

Business description

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.

Management board & Supervisory board

Guillaume Daniellot
Management board
Dr. Peter Hackel, Alastair Robertson, Aurelio Sahagun, Camila Finzi, Christian Ullrich, Dirk Reznik, Holger Haderer, Mark Johnson, Matthias Schupp, Patrick Kok-Kien Loh, Rahma Samow, Wolfgang Becker
Supervisory board
Gilbert Achermann, Dr. Beat Lüthi, Dr. Thomas Straumann, Juan-José Gonzalez, Marco Gadola, Nadia Tarolli Schmidt, Petra Rumpf, Regula Wallimann

Company data

Name: Straumann Holding AG
Address: Peter Merian-Weg 12,CH-4052 Basel
Phone: +41-61-965-1111
Fax: +41-61-965-1101
E-mail: info@straumann.com
Internet: www.straumann.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 57.90%
IPO date: -

Investor relations

Name: Fabian Hildbrand
IR phone: +41-61-965-1327
IR Fax: -
IR e-mail: investor.relations@s...ann.com investor.relations@straumann.com

Main Shareholders

Dr. h.c. Thomas Straumann
Dr. h.c. Rudolf Maag
Simone Maag de Moura Cunha
Gabriella Straumann